Single Dose Antenatal Corticosteroids (SNACS) for Women at Risk of Preterm Birth
Status:
Recruiting
Trial end date:
2021-08-31
Target enrollment:
Participant gender:
Summary
Antenatal corticosteroids (ACS) reduce the risks of neonatal death and morbidities, such as
respiratory distress syndrome, in preterm infants.
Standard of care for women at risk of preterm birth includes 2 doses of 12 mg betamethasone
(for a total of 24 mg) to accelerate fetal lung maturity.
We plan to conduct a pilot clinical trial to determine the feasibility of a trial comparing
half the usual dose (total 12 mg) of betamethasone to the standard double dose (total 24 mg)
of betamethasone.